Compare ABVC & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABVC | GROW |
|---|---|---|
| Founded | 2015 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.6M | 32.7M |
| IPO Year | 2009 | 1995 |
| Metric | ABVC | GROW |
|---|---|---|
| Price | $1.04 | $2.96 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 149.6K | 16.0K |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 3.53% |
| EPS Growth | ★ 7.14 | N/A |
| EPS | N/A | ★ 0.27 |
| Revenue | $509,589.00 | ★ $23,850,609.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $10.59 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.88 | $2.23 |
| 52 Week High | $3.39 | $3.65 |
| Indicator | ABVC | GROW |
|---|---|---|
| Relative Strength Index (RSI) | 37.18 | 49.54 |
| Support Level | $0.96 | $2.89 |
| Resistance Level | $1.15 | $3.26 |
| Average True Range (ATR) | 0.10 | 0.09 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 14.29 | 45.24 |
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.